On Monday night, reports surfaced that a senior fellow at the New York City-based Progressive Policy Institute who served as former CEO of several drug and device companies is being considered by President Donald Trump to head the U.S. Food and Drug Administration.
The news, reported by STAT News, caught my eye because I interviewed him less than a year ago about his views on how the FDA should change its focus. In fact, my February 2016 article on Dr. Joseph Gulfo, headlined “Meet FDA critic…
On Monday night, reports surfaced that a senior fellow at the New York City-based Progressive Policy Institute who served as former CEO of several drug and device companies is being considered by President Donald Trump to head the U.S. Food and Drug Administration.
The news, reported by STAT News, caught my eye because I interviewed him less than a year ago about his views on how the FDA should change its focus. In fact, my February 2016 article on Dr. Joseph Gulfo, headlined “Meet FDA critic…